Evidence map›Paper›PMID 41028027›Full record

ArticleScientific reports2025

An advanced skin lesion segmentation and classification framework using deep learning strategies.

J Deepa, P Madhavan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J DeepaDepartment of Computing Technologies, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India.
P MadhavanDepartment of Computing Technologies, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India. madhavap@srmist.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin cancer is a deadly kind of cancer that grows rapidly and produces life-threatening issues within six weeks from the initial stage. Accurate analysis is needed for observing both the malignant and benign skin lesions that are more complicated to ensure the essential treatment for the individuals. The best solution to perform automatic skin lesion categorization is to employ deep learning systems that are trained from a huge amount of benchmark data. Moreover, melanoma is referred to as a crucial skin cancer that badly affects entire human health and also their life. In this case, early-stage melanoma diagnosis is more complicated due to the presence of color changes in the same lesion. Hence, to overcome these complications in the traditional techniques, a novel automated skin lesion segmentation model is required to provide effective diagnosis results. The collected images are applied to the preprocessing stage to enhance quality. The pre-processed images are given to the segmentation stage by utilizing an Adaptive Layer-based Visual Transformer with UNet (AL-VTransUNet), where the variables are tuned with Improved Random Parameter-based Galactic Swarm Optimization (IRP-GSO). Ultimately, the segmented images are subjected to the Dilated DenseNet with a Multi-Head Attention mechanism (DD-MHA) for classifying the outcomes. Here, the variable is also tuned with the support of the same IRP-GSO algorithm for improving classification effectiveness. Thus, the efficiency of the recommended framework is examined using existing optimization and classification approaches.

Indexed as

Deep LearningImage Processing, Computer-AssistedMelanomaSkin NeoplasmsAlgorithmsHumansSkinAdaptive layer-based visual transformer with UNetDilated densenet with multi-head attention mechanismImproved random parameter-based galactic swarm optimizationSkin lesion segmentation and classification

Identifiers

PMID41028027
PMCPMC12485202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.